Recombinant Human ASK1 Protein，His

ASK1 (Apoptosis Signal-regulating Kinase 1) is a member of the MAPK (mitogen-activated protein kinase) kinase family, and it plays a critical role in cellular stress responses, inflammation, and apoptosis. Dysregulation of ASK1 is implicated in various diseases, including cancer, neurodegenerative disorders, and cardiovascular diseases, making it a significant target for therapeutic intervention. The activation of ASK1 is often triggered by oxidative stress and pro-inflammatory cytokines, leading to the activation of downstream signaling pathways such as the JNK (c-Jun N-terminal kinase) and p38 MAPK pathways, which ultimately result in programmed cell death. Research on ASK1 has focused on understanding its molecular mechanisms, identifying potential inhibitors or activators, and exploring its role in specific disease contexts. The development of ASK1-targeted therapies aims to mitigate its pathological effects, offering hope for novel treatments. Moreover, the production of recombinant ASK1 protein has facilitated the study of its biochemical properties and regulatory mechanisms. These recombinant proteins are essential for conducting in vitro assays and structural biology studies, ultimately enhancing our understanding of this kinase's functions and its potential as a drug target. Recent advancements in biotechnological methods have enabled more efficient expression and purification of ASK1, allowing for detailed investigations into its structure-function relationships and interactions with other signaling molecules. Overall, the study of ASK1 and its recombinant forms is crucial for elucidating its role in health and disease, paving the way for innovative therapeutic strategies.